Holen Sie sich die Stockscreener-App
47.80
1.81%
0.85
Handel nachbörslich:
47.82
0.02
+0.04%
Schlusskurs vom Vortag:
$46.95
Offen:
$46.92
24-Stunden-Volumen:
15.44M
Relative Volume:
0.78
Marktkapitalisierung:
$69.27B
Einnahmen:
$20.62B
Nettoeinkommen (Verlust:
$3.56B
KGV:
20.04
EPS:
2.3847
Netto-Cashflow:
$3.48B
1W Leistung:
+2.05%
1M Leistung:
-2.63%
6M Leistung:
-33.80%
1J Leistung:
-55.45%
1-Tages-Spanne:
$46.83
$48.06
1-Wochen-Bereich:
$46.09
$49.66
52-Wochen-Spanne:
$42.20
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, MDT, SYK, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-30 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Herabstufung | Erste Group | Buy → Hold |
| 2025-09-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Boston Scientific stock gains support from institutional buying and solid Q2 2026 results - AD HOC NEWS
Update on recent cybersecurity incident - Boston Scientific
Recall Recap: Boston Scientific Pacemakers, Baby Formula - Law360
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk - Benzinga
Renal Denervation Market Size, Share & Trends Analysis - GlobeNewswire Inc.
Boston Scientific (NYSE:BSX) Trades Below Its Cash-Flow Value - kalkinemedia.com
Boston Scientific Corp Stock Price Live, Charts & News - The Economic Times
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Vanguard PRIMECAP Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (NYSE:BSX) Closes In on Its Landmark Penumbra Deal - kalkinemedia.com
How Is Boston Scientific's Stock Performance Compared to Other Medical Device Stocks? - Barchart.com
Boston Scientific (NYSE: BSX) EVP’s 1,171-share award partly withheld for taxes - Stock Titan
Boston Scientific options surge signals institutional bet on year-end recovery - Investing.com
Healthcare cyberattacks hit pacemakers and millions of patient records - The Register
Is It Too Late to Buy Boston Scientific Corp (BSX) After 3.1% Ra - GuruFocus
Boston Scientific Working to Restore Shipments After Cyberattack - marketscreener.com
Boston Scientific faces ongoing operational disruption after cybersecurity incident impacts IT systems, order processing - industrialcyber.co
Boston Scientific Corp (BSX) Insider Susan Morano Buys 2,040 Sha - GuruFocus
Boston Scientific director Susan Morano buys $100,407 in shares - Investing.com
Boston Scientific (BSX) Faces Disruption from Cyber Attack - GuruFocus
Boston Scientific Targeted in Cyberattack - Medical Product Outsourcing
Boston Scientific reports global IT disruption from cybersecurity incident, shipment delays possible - TradingView
Boston Scientific Says Cyberattack Disrupting Global Operations -- Update - marketscreener.com
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
Boston Scientific stock holds steady as institutional buyers build positions - Ad-hoc-news.de
Boston Scientific (NYSE:BSX) Gains Focus After Healthcare Shift - Kalkine Media
BSX|Boston Scientific Corp|Price:49.740|Chg%:+0.370 - TradingKey
Edmond DE Rothschild Holding S.A. Acquires Shares of 875,810 Boston Scientific Corporation $BSX - MarketBeat
A Look at Boston Scientific Corp (BSX) After 3.0% Gain -- GF Val - GuruFocus
Boston Scientific stock trades around $50 as Q2 2026 margins and earnings expand - AD HOC NEWS
Great Lakes Advisors LLC Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Boston Scientific stock holds in the low $51 range as Q2 2026 margins and EPS beat guidance - AD HOC NEWS
Boston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks - AboutLawsuits.com
Mitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Faces Growth Concerns in Key Medical Device Franchises - Yahoo Finance
Boston Scientific stock extends 7-day rebound as Q2 2026 margins expand - AD HOC NEWS
If You Invested $1000 In Boston Scientific Stock 15 Years Ago, You Would Have This Much Today - Benzinga
Trivium Point Advisory LLC Invests $1.48 Million in Boston Scientific Corporation $BSX - MarketBeat
S&CO Inc. Buys Shares of 169,791 Boston Scientific Corporation $BSX - MarketBeat
AAFMAA Wealth Management & Trust LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Mill Capital Management LLC Invests $9.85 Million in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Looks Cheap On Earnings And Fair Value - simplywall.st
Congress Large Cap Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific (BSX), What Is Behind The Latest Investor Attention? - finance.yahoo.com
Is Boston Scientific’s (BSX) Buyback at Odds with Its Lower 2026 Growth Guidance? - Yahoo Finance
Fidelity Blue Chip Growth Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) Still Undervalued After A 50% Fall? - Yahoo Finance
Brazil CADE reviews Boston Scientific’s acquisition of Penumbra - MLex
Boston Scientific (BSX) Faces Growth Slowdown in Key Businesses - Yahoo Finance
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Boston Scientific Corp-Aktie (BSX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Habiger David C | Director |
Aug 05 '26 |
Buy |
47.59 |
2,100 |
99,937 |
17,160 |
| Habiger David C | Director |
Aug 03 '26 |
Buy |
48.07 |
1,042 |
50,084 |
14,920 |
| Habiger David C | Director |
Aug 04 '26 |
Buy |
48.59 |
140 |
6,802 |
15,060 |
| Mahoney Michael F | Chairman, President & CEO |
Aug 03 '26 |
Buy |
48.33 |
186,240 |
9,001,408 |
1,590,024 |
| LUDWIG EDWARD J | Director |
Jul 31 '26 |
Buy |
45.48 |
5,000 |
227,400 |
30,359 |
| Monson Jonathan | EVP and CFO |
Jul 01 '26 |
Option Exercise |
0.00 |
2,087 |
0 |
40,073 |
| Pegus Cheryl | Director |
May 20 '26 |
Buy |
56.49 |
1,770 |
99,987 |
1,770 |
| LUDWIG EDWARD J | Director |
May 20 '26 |
Buy |
56.68 |
3,580 |
202,914 |
25,359 |
| Habiger David C | Director |
May 20 '26 |
Buy |
55.92 |
2,250 |
125,819 |
13,878 |
| Habiger David C | Director |
May 19 '26 |
Buy |
56.95 |
2,200 |
125,279 |
11,628 |
0.13%
2.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):